Drug intelligence / Profile preview

small mobile stem cells

Development stage
Phase 1
Lead developer
SMSbiotech
Modality
Stem Cell Therapies → Cell Therapies
Administration
Inhalation
01

Overview

Small Mobile Stem Cells (SMS cells) are a novel preparation of human adult stem cells characterized by their small size and enhanced mobility. They are being investigated for their regenerative potential, particularly in chronic obstructive pulmonary disease (COPD), aiming to promote lung repair by modulating the gene expression of alveolar progenitor cells (especially alveolar type 2 cells). SMS cells have demonstrated the ability to upregulate pro-regenerative pathways and suppress inflammation and necrosis at a molecular level. SORT-COPD (SMS cells) represents the first-in-human, inhaled stem cell therapy approach for respiratory diseases. The cells are delivered directly to the lungs via nebulization in clinical trials, with ongoing research focusing on their safety and biological activity in COPD and related degenerative lung diseases[1][2][3][6].

Brand names
SORT COPD
Other names
SMS cellsSmall Mobile Stem Cells

Beyond the preview

Go deeper on small mobile stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on small mobile stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call